Jeffrey Czum
Radon Exposure: Danger Lurks in Our Home
A wealth of data and evidence has determined that radon gas develops into lung cancer. It remains less debatable that radon presents a concern to occupants within a household and those that occupy a building.
Marty (2020) mentions that radon is a radioactive noble gas that occurs naturally in the ground, while uranium goes through a decay process. Since the decay process happens in the earth, radon found in rock and soil can escape, allowing individuals to inhale the dangerous gas. When radon escapes to the outdoors, it dilutes rapidly and does not cause human health problems. However, indoor radon concentrations become a much bigger problem when an individual inhales radon in a more massive dose over time. Inhaling the carcinogen deposits the radioactive particles in the airway lung lining and creates problems.
The Martha s Vineyard Times Balancing Act, oil on paper, framed to 20.5 x 25.5 in. Courtesy Michaele Christian Black Lives Matter Prototype, mixed media, 11 x 15 in. unframed. Courtesy Michaele Christian Descent, collagraph, oil on ink paper, framed to 18.25 x 15.25 in. Courtesy Michaele Christian Dream On 1 Courtesy Michaele Christian Garden of My Dreams 1, oil on paper, framed to 19 x 26 in. Courtesy Michaele Christian Red Rising, monotype, oil on paper, framed to 16 x 10 in. Courtesy Michaele Christian The Lurch 1, oil on paper, framed to 16 x 14 in. Courtesy Michaele Christian
Untitled 119, oil on ink paper, framed to 20.5 x 24.25 in. Courtesy Michaele Christian
Untitled 418, monotype, oil on paper, 23.125 x 19.5 in. Courtesy Michaele Christian
Legendary Oncologist Emil J Freireich, MD, Dies at 93 medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
email article
Neoadjuvant chemotherapy is the treatment of choice for newly diagnosed inflammatory or unresectable breast cancer, as well as locally advanced disease that might be rendered operable with neoadjuvant therapy, according to a new guideline from the American Society of Clinical Oncology (ASCO).
A limited number of factors have sufficient evidence to support routine use of clinical decision-making: tumor histology, grade, stage, and hormone receptor (HR) status (estrogen, progesterone, and HER2). Data remain insufficient to support use of other markers or genomic profiling to inform decisions about neoadjuvant chemotherapy, stated guideline panel co-chairs Larissa A. Korde, MD, of the National Cancer Institute in Bethesda, Maryland, and Dawn L. Hershman, MD, of Columbia University in New York City, and co-authors in the